Method
Level · gp.fundamentals.debt_to_revenue
Raw value 161.79% · OPTIONAL
· Pharmaceutical Preparations
RESEARCH SNAPSHOTPHIBRO ANIMAL HEALTH CORP's latest supported as-filed period reports revenue of $383.5M; gross margin moved 270 basis points higher on the same comparison basis. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.debt_to_revenue
Raw value 161.79% · OPTIONAL
Level · gp.fundamentals.capex_revenue_ratio
Raw value 3.99% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 4.23% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 10.27% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 140.71% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 32.77% · CORE
Level · gp.fundamentals.operating_margin
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed -9.0% from the comparable as-filed period.
Debt changed -2.3% from the comparable as-filed period.
Gross margin changed +270 basis points from the comparable as-filed period.
Gross profit changed +20.2% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
PAHC · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001104659-26-093397SEC ↗4Aug 10, 2026Period Aug 6, 20260001104659-26-093394SEC ↗4Aug 10, 2026Period Aug 6, 20260001104659-26-093391SEC ↗4Aug 10, 2026Period Aug 6, 20260001104659-26-093388SEC ↗4Aug 10, 2026Period Aug 6, 20260001104659-26-093387SEC ↗4Aug 10, 2026Period Aug 6, 20260001104659-26-093385SEC ↗4Aug 10, 2026Period Aug 6, 20260001104659-26-093383SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 6, 2026Filed Aug 10, 2026 | Rodriguez PatrickVP Finance and Treasurer | Grant Or AwardDirect | 1,503 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Raw value 11.64% · CORE
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 0.11% · OPTIONAL
Inventory changed +20.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Net income changed +15.1% from the comparable as-filed period.
Operating income changed +33.2% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-03-31. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001104659-26-093378